TRAX · First Tracks Biotherapeutics, Inc. · Investor Relations
$44.79
+0.29 (+0.65%)
At close · Nov 19
Return incl. dividend (before tax)
Market Cap
$1.87B
Shares
42.02M
Volume · Nov 19
98.53K
Avg daily vol (3M)
827.63K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-12-01 18:30 UTC | Piper Sandler 38th Annual Healthcare Conference | Conference |
| 2026-12-02 17:30 UTC | 9th Annual Evercore Healthcare Conference | Conference |
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-11-17 | UBS Global Biopharma Conference 2026 | Conference |
| 2026-11-16 | Jefferies Global Healthcare Conference | Conference |
| 2026-11-10 | Guggenheim 3rd Annual Healthcare Innovation Conference | Conference |
| 2026-10-12 | First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease | Earnings call |
| 2026-10-12 | ANB033 Top-Line Phase 1b Cohort 1 Results in Celiac Disease | Event |
| 2026-09-09 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
Source: https://ir.firsttracksbio.com/
Key facts
CIK
2091349
CUSIP
337185102
13F (30d)
178 filings
175 filers
Visit website
Investor relations